Research output per year
Research output per year
Personal profile
Current research
PhD project: Improving medicine risk communication to general practitioners
Every day general practioners receive all kinds of new information about new medicines and new research. But what do they need in their everyday practice in front of their patients? How can we secure that they receive vital information about newly discovered medicine risk? Normally physicians and HCPs receive this kind of information in a letter. But that mode of communication in not very beneficial to physicians nor patients.
For those reasons this project sets out to understand how general practitioners prefer receiving this information and what is important for them to know about medicine. With this knowledge future communications may better support the decisions they make when prescribing medicine.
Short presentation
PhD project ”Factors ensuring effective Direct to Healthcare Professional Communication of Risk Minimization Initiatives”
Research interests
I am primarily interested in
- Risk communication in the regulation of pharmaceuticals
- Rhetoric of medicine
- Communication practices in the pharmaceutical sector
Qualitative methods
I work with qualitative and text-oriented methods such as
- Rhetorical analysis and criticism, e.g. argumentation, style and ideology
- Semi-structured interviews
- Focus group interviews
- Protocol analysis
Education/Academic qualification
Fingerprint
Dive into the research topics where Mathias Møllebæk is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 4 Similar Profiles
Research output
-
Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA
Fanø, A. B., Møllebæk, M. & Kaae, S., 2019, In: Therapeutic Innovation & Regulatory Science. 1-9, DOI: 10.1177/2168479019871041Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Rhetoric and STS
Møllebæk, M., 1 Sept 2019, (Accepted/In press) Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research. Bahri, P. (ed.). SpringerResearch output: Chapter in Book/Report/Conference proceeding › Book chapter › Research
-
The effectiveness of direct to healthcare professional communication – A systematic review of communication factor studies
Møllebæk, M., Kaae, S., De Bruin, M. L., Callréus, T., Jossan, S. & Hallgreen, C. E., May 2019, In: Research in Social and Administrative Pharmacy. 15, 5, p. 475-482Research output: Contribution to journal › Review › peer-review
-
Health and Human Rights: Ethical Issues of Outsourcing Clinical Trials
Møllebæk, M., 8 Dec 2018Research output: Other contribution › Net publication - Internet publication › Research
-
Public hearings as a transparency measure: The Valproate case
Møllebæk, M., 2 Oct 2017.Research output: Contribution to conference › Conference abstract for conference › Research
-
Rhetoric of science in the regulation of medicines in Denmark
Møllebæk, M., 5 Jul 2017Research output: Other contribution › Net publication - Internet publication › Research
Activities
-
Post-marketing risk communication: How do Danish GPs read letters from regulators and industry about emergent risks?
Mathias Møllebæk (Speaker)
23 Aug 2019Activity: Talk or presentation types › Lecture and oral contribution
-
Post-marketing risk communication: How do Danish GPs read letters from regulators and industry about emergent risks?
Mathias Møllebæk (Speaker)
24 Jun 2019Activity: Talk or presentation types › Lecture and oral contribution
-
Tracing medical risk rhetoric from regulatory database to clinical judgment – an interview and protocol study
Mathias Møllebæk (Speaker)
26 Apr 2019Activity: Talk or presentation types › Lecture and oral contribution
-
How do Danish PCPs read regulatory drug warnings?
Mathias Møllebæk (Speaker)
13 Jan 2019Activity: Talk or presentation types › Lecture and oral contribution
-
CORS Annual Conference 2018: Impact of drug regulation on health and society
Marie Louise (Marieke) De Bruin (Organizer), Theis Lange (Organizer), Nikolai C Brun (Organizer), Jens Heisterberg (Organizer), Louise C. Druedahl (Speaker), Christine Erikstrup Hallgreen (Speaker), Mette Gørtz (Speaker), Hubertus Gerardus Maria Leufkens (Speaker), Mathias Møllebæk (Speaker) & Per Sindahl (Speaker)
19 Nov 2018Activity: Participating in or organising an event types › Organisation of and participation in conference
-
Contemporary Social Pharmacy
Lotte Stig Nørgaard (Invited speaker), Lourdes Cantarero Arevalo (Other), Mathias Møllebæk (Other) & Nina Louise Fynbo Riis (Speaker)
27 Aug 2018Activity: Talk or presentation types › Lecture and oral contribution
-
Nordic PhD Symposium in Social and Clinical Pharmacy 2018June 13th-15th in Copenhagen
Lotte Stig Nørgaard (Invited speaker) & Mathias Møllebæk (Organizer)
15 Jun 2018Activity: Participating in or organising an event types › Participation in workshop, seminar, course
-
Communicating your research
Lotte Stig Nørgaard (Invited speaker) & Mathias Møllebæk (Lecturer)
15 Jun 2018Activity: Talk or presentation types › Lecture and oral contribution